Clincosm LogoSign in Get a demo

c3 glomerulopathy

Showing 1 - 12 of 12
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adenine Phosphoribosyltransferase Deficiency, AH Amyloidosis, AHL Amyloidosis Trial in Bristol

Recruiting
  • Adenine Phosphoribosyltransferase Deficiency
  • +83 more
    • Bristol, South West, United Kingdom
      Zoe Plummer
    Sep 26, 2023

    C3G, IC-MPGN, C3 Glomerulopathy Trial (Pegcetacoplan)

    Not yet recruiting
    • C3G
    • +11 more
    • (no location specified)
    Apr 13, 2023

    C3 Glomerulopathy Trial (NM8074)

    Not yet recruiting
    • C3 Glomerulopathy
    • (no location specified)
    Jan 12, 2023

    C3 Glomerulopathy, C3 Glomerulonephritis, Dense Deposit Disease Trial in United Kingdom, United States (Danicopan, Placebo)

    Completed
    Has Results
    • C3 Glomerulopathy
    • +2 more
    • Aurora, Colorado
    • +6 more
    Oct 7, 2022

    Paroxysmal Nocturnal Hemoglobinuria, C3 Glomerulopathy, IgA Nephropathy Trial in Korea, Republic of, New Zealand, Thailand

    Recruiting
    • Paroxysmal Nocturnal Hemoglobinuria
    • +2 more
    • Camperdown, New South Wales, Australia
    • +19 more
    Sep 13, 2022

    C3 Glomerulonephritis, C3 Glomerulopathy, Immune Complex Membranoproliferative Glomerulonephritis Trial in Worldwide (Danicopan)

    Terminated
    Has Results
    • C3 Glomerulonephritis
    • +4 more
    • Birmingham, Alabama
    • +12 more
    Aug 9, 2022

    C3G, IC-MPGN, C3 Glomerulopathy Trial in Worldwide (Pegcetacoplan, Placebo)

    Recruiting
    • C3G
    • +11 more
    • Birmingham, Alabama
    • +27 more
    Aug 4, 2022

    C3G, IC-MPGN, Renal Transplant Trial in Worldwide (Pegcetacoplan)

    Recruiting
    • C3G
    • +11 more
    • Los Angeles, California
    • +21 more
    Apr 5, 2022

    C3 Glomerulopathy, Membranoproliferative Glomerulonephritis, Complement Abnormality Trial in Sweden (Aliskiren, Enalapril)

    Recruiting
    • C3 Glomerulopathy
    • +4 more
    • Gothenburg, Sweden
    • +3 more
    Jan 4, 2022

    C3 Glomerulonephritis, C3 Glomerulopathy, Immune Complex Membranoproliferative Glomerulonephritis Trial in Ranica (Non

    Completed
    • C3 Glomerulonephritis
    • +4 more
    • Non contrast-enhanced magnetic resonance imaging
    • Ranica, BG, Italy
      Centro di Ricerche Cliniche per le Malattie Rare Aldo e Cele Dac
    Nov 24, 2021

    C3 Glomerulonephritis, Dense Deposit Disease, C3 Glomerulopathy Trial in Melbourne, Antwerpen, Leiden (Danicopan)

    Completed
    Has Results
    • C3 Glomerulonephritis
    • +4 more
    • Melbourne, Australia
    • +2 more
    Oct 7, 2021

    IgAN, Lupus Nephritis, MN Trial in Hong Kong, United States (OMS721 (narsoplimab))

    Unknown status
    • IgAN
    • +3 more
    • OMS721 (narsoplimab)
    • Denver, Colorado
    • +11 more
    Apr 8, 2020